FARMINGDALE, N.Y.----Misonix, Inc. , a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, has received 510 clearance from the U.S.

Meditrina Pharmaceuticals, Inc. announced the approval of its second investigational new drug (IND) application for a Phase IIb dose ranging clinical trial to study MPI-676, the Company's aromatase inhibitor (AI), in combination with estrogen and progest

Distinguished medical experts in the burgeoning field of interventional therapies for congenital and structural heart disease will gather in Las Vegas July 20-23 for the Pediatric & Adult Interventional Cardiac Symposium (PICS/AICS). Specialists from Rush

FARMINGDALE, N.Y.----Misonix, Inc. , a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, has entered into a new, three year, exclusive

Dennis McCullough, geriatrician and family physician for 30 years, currently practicing at Kendal at Hanover Continuing Care Community and Dartmouth Medical School, makes a case for "slow medicine" in his new book "My Mother, Your Mother: Embracing 'S